The c-Jun N-terminal kinases in cerebral microglia: Immunological functions in the brain

Biochemical Pharmacology

Volumn 64, Issue 5-6, 2002, Pages 781-788

  Hidding, Ute ^a   Mielke, Kirsten ^a   Waetzig, Vicki ^a   Brecht, Stephan ^a   Hanisch, Uwe ^b   Behrens, Alexander ^c   Wagner, Erwin ^c   Herdegen, Thomas ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

c Jun; c Jun N terminal kinases; Immune cells; Microglia; Mixed lineage kinases; Neurodegeneration

Indexed keywords

CYTOKINE; ENZYME INHIBITOR; INTERLEUKIN 12; INTERLEUKIN 6; ISOENZYME; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN; STRESS ACTIVATED PROTEIN KINASE; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ARTICLE; ASSOCIATION; BRAIN CORTEX; BRAIN FUNCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INHIBITION; GENE EXPRESSION; IMMUNOCOMPETENT CELL; INCUBATION TIME; INFLAMMATION; MICROGLIA; MORPHOLOGY; MUTATION; NERVE CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REINFORCEMENT; TIME;

ANIMALS; BRAIN; CELLS, CULTURED; CEREBRAL CORTEX; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS;

EID: 0036710505     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01139-5     Document Type: Article

References (43)

1. Davis R.J. Signal transduction by the c-Jun N-terminal kinase. Biochem. Soc. Symp. 64:1999;1-12.
2. Waetzig V. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene. 20(19):2001;2424-2437.
3. Ham J., Eilers A., Whitfield J., Neame S.J., Shah B. c-Jun and the transcriptional control of neuronal apoptosis. Biochem. Pharmacol. 60(8):2000;1015-1021.
4. Park J., Kim I., Oh Y.J., Lee K., Han P.L., Choi E.J. Activation of c-Jun N-terminal kinase antagonizes an antiapoptotic action of Bcl-2. J. Biol. Chem. 272(27):1997;16725-16728.
5. Bhat N.R., Zhang P. Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J. Neurochem. 72(1):1999;112-119.
6. Brownlees J., Yates A., Bajaj N.P., Davis D., Anderton B.H., Leigh P.N., Shaw C.E., Miller C.C. Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J. Cell. Sci. 113(Pt 3):2000;401-407.
7. Rincon M., Whitmarsh A., Yang D.D., Weiss L., Derijard B., Jayaraj P., Davis R.J., Flavell R.A. The JNK pathway regulates the in vivo deletion of immature CD4(+)CD8(+) thymocytes. J. Exp. Med. 188(10):1998;1817-1830.
8. Sabapathy K., Hu Y., Kallunki T., Schreiber M., David J.P., Jochum W., Wagner E.F., Karin M. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9(3):1999;116-125.
9. Yang D.D., Conze D., Whitmarsh A.J., Barrett T., Davis R.J., Rincon M., Flavell R.A. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity. 9(4):1998;575-585.
10. Li B., Tournier C., Davis R.J., Flavell R.A. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J. 18(2):1999;420-432.
11. Faris M., Kokot N., Lee L., Nel A.E. Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in jurkat T cells: evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation. J. Biol. Chem. 271(44):1996;27366-27373.
12. Chen C.Y., Del Gatto-Konczak F., Wu Z., Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science. 280(5371):1998;1945-1949.
13. Dong C., Yang D.D., Tournier C., Whitmarsh A.J., Xu J., Davis R.J., Flavell R.A. JNK is required for effector T-cell function but not for T-cell activation. Nature. 405(6782):2000;91-94.
14. Klettner A., Baumgrass R., Zhang Y., Fischer G., Burger E., Herdegen T., Mielke K. The neuroprotective actions of FK506 binding protein ligands: neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and calcineurin. Brain Res. Mol. Brain Res. 97(1):2001;21-31.
15. Chow C.W., Dong C., Flavell R.A., Davis R.J. c-Jun NH(2)-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1. Mol. Cell. Biol. 20(14):2000;5227-5234.
16. Lenczowski J.M., Dominguez L., Eder A.M., King L.B., Zacharchuk C.M., Ashwell J.D. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell. Biol. 17(1):1997;170-181.
17. Skov S. Intracellular signal transduction mediated by ligation of MHC class I molecules. Tissue Antigens. 51(3):1998;215-223.
18. Skov S., Klausen P., Claesson M.H. Ligation of major histocompatability complex (MHC) class I molecules on human T cells induces cell death through PI-3 kinase-induced c-Jun NH2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis. J. Cell. Biol. 139(6):1997;1523-1531.
19. Smith A., Ramos-Morales F., Ashworth A., Collins M. A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells. Curr. Biol. 7(11):1997;893-896.
20. Tuyt L.M., Dokter W.H., Birkenkamp K., Koopmans S.B., Lummen C., Kruijer W., Vellenga E. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. J. Immunol. 162(8):1999;4893-4902.
21. Rose D.M., Winston B.W., Chan E.D., Riches D.W., Gerwins P., Johnson G.L., Henson P.M. Fc gamma receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages: role for p42MAPK in Fc gamma receptor-stimulated TNF-alpha synthesis. J. Immunol. 158(7):1997;3433-3438.
22. Ishizuka T., Terada N., Gerwins P., Hamelmann E., Oshiba A G.R., Johnson G.L., Gelfand E.W. Mast cell tumor necrosis factor alpha production is regulated by MEK kinases. Proc. Natl. Acad. Sci. U.S.A. 94(12):1997;6358-6363.
23. Min W., Pober J.S. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways. J. Immunol. 159(7):1997;3508-3518.
24. Read M.A., Whitley M.Z., Gupta S., Pierce J.W., Best J., Davis R.J., Collins T. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 272(5):1997;2753-2761.
25. Hanisch U.K., Prinz M., Angstwurm K., Hausler K.G., Kann O., Kettenmann H., Weber J.R. The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. Eur. J. Immunol. 31(7):2001;2104-2115.
26. Koistinaho M., Kettunen M.I., Goldsteins G., Keinanen R., Salminen A., Ort M., Bures J., Liu D., Kauppinen R.A., Higgins L.S., Koistinaho J. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc. Natl. Acad. Sci. U.S.A. 99(3):2002;1610-1615.
27. Ryu J., Pyo H., Jou I., Joe E. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B. J. Biol. Chem. 275(39):2000;29955-29959.
28. Pocock J.M., Liddle A.C. Microglial signalling cascades in neurodegenerative disease. Prog. Brain Res. 132:2001;555-565.
29. Pyo H., Jou I., Jung S., Hong S., Joe E.H. Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. Neuroreport. 9(5):1998;871-874.
30. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21(8):2001;2580-2588.
31. Raivich G., Bohatschek M., Kloss C.U., Werner A., Jones L.L., Kreutzberg G.W. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res. Brain Res. Rev. 30(1):1999;77-105.
32. Zhang P., Hogan E.L., Bhat N.R. Activation of JNK/SAPK in primary glial cultures: II. Differential activation of kinase isoforms corresponds to their differential expression. Neurochem. Res. 23(2):1998;219-225.
33. Migheli A., Piva R., Atzori C., Troost D., Schiffer D. c-Jun JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 56(12):1997;1314-1322.
34. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 389(6653):1997;865-870.
35. Yamazaki Y., Shikamoto Y., Fukudome K., Kimoto M., Morita T. Fibroblasts, glial, and neuronal cells are involved in extravascular prothrombin activation. J. Biochem. (Tokyo). 126(4):1999;655-661.
36. Moller T., Hanisch U.K., Ransom B.R. Thrombin-induced activation of cultured rodent microglia. J. Neurochem. 75(4):2000;1539-1547.
37. Coffey E.T., Hongisto V., Dickens M., Davis R.J., Courtney M.J. Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons. J. Neurosci. 20(20):2000;7602-7613.
38. Murakata C., Kaneko M., Gessner G., Angeles T.S., Ator M.A., O'Kane T.M., McKenna B.A., Thomas B.A., Mathiasen J.R., Saporito M.S., Bozyczko-Coyne D., Hudkins R.L. Mixed lineage kinase activity of indolocarbazole analogues. Bioorg. Med. Chem. Lett. 12(2):2002;147-150.
39. Maroney A.C., Finn J.P., Bozyczko-Coyne D., O'Kane T.M., Neff N.T., Tolkovsky A.M., Park D.S., Yan C.Y., Troy C.M., Greene L.A. CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. J. Neurochem. 73(5):1999;1901-1912.
40. Maroney A.C., Finn J.P., Connors T.J., Durkin J.T., Angeles T., Gessner G., Xu Z., Meyer S.L., Savage M.J., Greene L.A., Scott R.W., Vaught J.L. Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J. Biol. Chem. 276(27):2001;25302-25308.
41. Behrens A., Sibilia M., Wagner E.F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet. 21(3):1999;326-329.
42. Mielke K., Damm A., Yang D.D., Herdegen T. Selective expression of JNK isoforms and stress-specific JNK activity in different neural cell lines. Brain Res. Mol. Brain Res. 75(1):2000;128-137.
43. Kahlke V., Angele M.K., Ayala A., Schwacha M.G., Cioffi W.G., Bland K.I., Chaudry I.H. Immune dysfunction following trauma-haemorrhage: influence of gender and age. Cytokine. 12(1):2000;69-77.